Maintaining Study Patient Engagement During the COVID-19 Emergency

The COVID-19 pandemic has caused an enormous disruption in healthcare priorities and staffing, and as restrictions on people’s movement have increased, clinical research sites face unprecedented challenges to adjust studies and patient engagement accordingly. The FDA has provided guidance to support ongoing continuity and response efforts, wherein the safety of trial participants is paramount. It […]

Learn More